|
Medical Privacy
BIO supports national legislation to protect the confidentiality of all individually identifiable medical information. We believe that this medical information must be respected, treated confidentially and safeguarded from discriminatory misuse.
- BIO's comments regarding the NPRM that proposes changes to the HIPAA privacy regulation (April 25, 2002)
- Testimony of Michael J. Werner, Esq.
before the Committee on Health, Education, Labor, and Pensions, hearing on Medical Privacy.
(April 16, 2002, 117KB PDF)
- Analysis of NPRM (March
21, 2002)
HHS Addresses Many of BIO's Concerns In Proposing Changes to the HIPAA
Privacy Regulation
- Testimony of Joanna C. Horobin, MD
on behalf of the Biotechnology Industry Organization (BIO), regarding
the Proposed Rule on Confidentiality of Patient Records Could Impede
Research before the Senate Health, Education, Labor and Pensions Committee.
(April 26, 2000)
- Comments on Proposed Standards
for Privacy of Individually Identifiable Health Information, by
the Biotechnology Industry Organization (BIO), addressed to Margaret
Ann Hamburg, M.D., Assistant Secretary for Planning and Evaluation,
U.S. Department of Health and Human Services. (Feb
17, 2000)
- Statement regarding confidentiality
of patient medical records, by the Biotechnology Industry Organization
(BIO), submitted to the Subcommittee on Health and the Environment House
Commerce Committee (May 27, 1999)
|
